Michael J. Parnham

3.0k total citations
55 papers, 2.4k citations indexed

About

Michael J. Parnham is a scholar working on Immunology, Molecular Biology and Toxicology. According to data from OpenAlex, Michael J. Parnham has authored 55 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 19 papers in Molecular Biology and 13 papers in Toxicology. Recurrent topics in Michael J. Parnham's work include Organoselenium and organotellurium chemistry (13 papers), Immune Response and Inflammation (7 papers) and Sphingolipid Metabolism and Signaling (6 papers). Michael J. Parnham is often cited by papers focused on Organoselenium and organotellurium chemistry (13 papers), Immune Response and Inflammation (7 papers) and Sphingolipid Metabolism and Signaling (6 papers). Michael J. Parnham collaborates with scholars based in Germany, Croatia and United States. Michael J. Parnham's co-authors include Helmut Sies, Erich Otto Graf, Gerd Geißlinger, Susanne Schiffmann, Frans P. Nijkamp, Jennifer Kurz, S. Leyck, Günter Lambrecht, Andreas Weigert and Vesna Eraković Haber and has published in prestigious journals such as Free Radical Biology and Medicine, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Michael J. Parnham

54 papers receiving 2.3k citations

Peers

Michael J. Parnham

TOXIC

IMMUN

Othman A. Al‐Shabanah Saudi Arabia

Deepak Sharma India

Hany A. Omar United Arab Emirates

Eun‐Hee Kim South Korea

Yih‐Shou Hsieh Taiwan

Muhammad Noman Khan Pakistan

Ralph Brattsand Sweden

Chi‐Cheng Lu Taiwan

Antonietta Rossi Italy

Shu‐Chen Chu Taiwan

Othman A. Al‐Shabanah Saudi Arabia

Michael J. Parnham

1.0k ×1.3

446 ×0.9

TOXIC

323 ×0.7

IMMUN

197 ×0.5

244 ×0.7

Citations per year, relative to Michael J. Parnham Michael J. Parnham (= 1×) peers Othman A. Al‐Shabanah

Countries citing papers authored by Michael J. Parnham

Since Specialization

Citations

This map shows the geographic impact of Michael J. Parnham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Parnham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Parnham more than expected).

Fields of papers citing papers by Michael J. Parnham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Parnham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Parnham. The network helps show where Michael J. Parnham may publish in the future.

Co-authorship network of co-authors of Michael J. Parnham

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Parnham. A scholar is included among the top collaborators of Michael J. Parnham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Parnham. Michael J. Parnham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parnham, Michael J., Virginia Norris, & Jennifer Kricker. (2025). Promoting immune defensive responses of epithelial cells in airway disease. Frontiers in Allergy. 6. 1697194–1697194.

Sies, Helmut & Michael J. Parnham. (2020). Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections. Free Radical Biology and Medicine. 156. 107–112. 135 indexed citations

Kutzner, Laura, Nerea Ferreirós, Michael J. Parnham, et al.. (2020). Long-term stimulation of toll-like receptor-2 and -4 upregulates 5-LO and 15-LO-2 expression thereby inducing a lipid mediator shift in human monocyte-derived macrophages. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(9). 158702–158702. 38 indexed citations

Han, Yingying, Javier Mora, Svenja Wiechmann, et al.. (2019). IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells. Cell Reports. 27(3). 835–846.e5. 78 indexed citations

Kurz, Jennifer, Michael J. Parnham, Gerd Geißlinger, & Susanne Schiffmann. (2018). Ceramides as Novel Disease Biomarkers. Trends in Molecular Medicine. 25(1). 20–32. 139 indexed citations

Geißlinger, Gerd, et al.. (2018). An in vitro test system for compounds that modulate human inflammatory macrophage polarization. European Journal of Pharmacology. 833. 328–338. 32 indexed citations

Linke, Bona, et al.. (2017). THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro. Molecular Immunology. 88. 58–68. 131 indexed citations

Wegner, Marthe-Susanna, Susanne Schiffmann, Michael J. Parnham, Gerd Geißlinger, & Sabine Grösch. (2016). The enigma of ceramide synthase regulation in mammalian cells. Progress in Lipid Research. 63. 93–119. 103 indexed citations

Labocha, Sandra, Nerea Ferreirós, Tobias Schmid, et al.. (2015). Identification and characterisation of a prototype for a new class of competitive PPARγ antagonists. European Journal of Pharmacology. 755. 16–26. 4 indexed citations

10.

Parnham, Michael J. & Helmut Sies. (2013). The early research and development of ebselen. Biochemical Pharmacology. 86(9). 1248–1253. 183 indexed citations

11.

Parnham, Michael J.. (2011). Immunomodulatory approaches to the treatment of infections. 31(1). 15–27. 6 indexed citations

12.

Bošnjak, Berislav, Boška Hrvačić, Martina Bosnar, et al.. (2006). Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. European Journal of Pharmacology. 539(1-2). 131–138. 77 indexed citations

13.

Čulić, Ognjen, Vesna Eraković Haber, Ivana Čepelak, et al.. (2002). Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. European Journal of Pharmacology. 450(3). 277–289. 181 indexed citations

14.

Griffiths, Helen R., et al.. (1992). The selective protection afforded by ebselen against lipid peroxidation in an ROS-dependent model of inflammation. Inflammation Research. 36(1-2). 107–111. 22 indexed citations

15.

Parnham, Michael J. & Ulrich Feige. (1992). Structural and functional properties of heat-shock proteins in inflammation and immunity. Inflammation Research. 35(1-2). 34–36. 7 indexed citations

16.

Parnham, Michael J.. (1990). Biological Activities and Clinical Potential of Ebselen. Advances in experimental medicine and biology. 264. 193–197. 13 indexed citations

17.

Leyck, S. & Michael J. Parnham. (1990). Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen. Inflammation Research. 30(3-4). 426–431. 28 indexed citations

18.

Parnham, Michael J., et al.. (1989). Structure-activity relationships of a series of anti-inflammatory benzisoselenazolones (BISAs). Inflammation Research. 27(3-4). 306–308. 51 indexed citations

19.

Parnham, Michael J. & Erich Otto Graf. (1987). Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochemical Pharmacology. 36(19). 3095–3102. 141 indexed citations

20.

Parnham, Michael J., et al.. (1987). Antagonist affinities for PAF receptors differentially depend on the degree of macrophage activation. Prostaglandins. 34(2). 175–175. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact